NCT04870944 2026-02-24CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and LymphomaChildren's Oncology GroupPhase 1/2 Recruiting63 enrolled
NCT05498792 2025-04-04Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in MelanomaFox Chase Cancer CenterPhase EARLY_PHASE1 Recruiting12 enrolled